159 related articles for article (PubMed ID: 37086173)
41. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases.
Michel M; Chanet V; Dechartres A; Morin AS; Piette JC; Cirasino L; Emilia G; Zaja F; Ruggeri M; Andrès E; Bierling P; Godeau B; Rodeghiero F
Blood; 2009 Oct; 114(15):3167-72. PubMed ID: 19638626
[TBL] [Abstract][Full Text] [Related]
42. Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome.
Diez-Feijóo R; Rodríguez-Sevilla JJ; Colomo L; Papaleo N; Maiques JM; Gimeno E; Andrade-Campos M; Abella E; Merchan BM; Calvo X; Jimenez C; Román-Bravo OD; Salar A; Sanchez-Gonzalez B
Thromb Res; 2021 Dec; 208():226-229. PubMed ID: 33714615
[TBL] [Abstract][Full Text] [Related]
43. Treatment and outcomes of immune cytopenias following solid organ transplant in children.
Schoettler M; Elisofon SA; Kim HB; Blume ED; Rodig N; Boyer D; Neufeld EJ; Grace RF
Pediatr Blood Cancer; 2015 Feb; 62(2):214-218. PubMed ID: 25308853
[TBL] [Abstract][Full Text] [Related]
44. Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study.
Zhang Z; Hu Q; Yang C; Chen M; Han B
Ann Med; 2023; 55(2):2282180. PubMed ID: 37967535
[TBL] [Abstract][Full Text] [Related]
45. Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Herishanu Y; Levi S; Kamdjou T; Bornstein Y; Ram R; Benyamini N; Varon D; Avivi I; Perry C
Br J Haematol; 2021 Jan; 192(1):e1-e4. PubMed ID: 33095444
[No Abstract] [Full Text] [Related]
46. A patient with mixed type Evans syndrome: efficacy of rituximab treatment.
Park CY; Chung CH
J Korean Med Sci; 2006 Dec; 21(6):1115-6. PubMed ID: 17179698
[TBL] [Abstract][Full Text] [Related]
47. Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.
Ducassou S; Leverger G; Fernandes H; Chambost H; Bertrand Y; Armari-Alla C; Nelken B; Monpoux F; Guitton C; Leblanc T; Fisher A; Lejars O; Jeziorski E; Fouissac F; Lutz P; Pasquet M; Pellier I; Piguet C; Vic P; Bayart S; Marie-Cardine A; Michel M; Perel Y; Aladjidi N
Br J Haematol; 2017 Jun; 177(5):751-758. PubMed ID: 28444729
[TBL] [Abstract][Full Text] [Related]
48. [The effectiveness of rituximab in refractory autoimmune thrombocytopenic purpura and haemolytic anaemia].
Martínez Velasco E; Gómez Castillo JJ; Fernández Megía MJ; González Joga B; Barreda Hernández D; Gómez Roncero MI
Farm Hosp; 2007; 31(2):124-7. PubMed ID: 17590122
[TBL] [Abstract][Full Text] [Related]
49. Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias.
Gómez-Almaguer D; Solano-Genesta M; Tarín-Arzaga L; Herrera-Garza JL; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Jaime-Pérez JC
Blood; 2010 Dec; 116(23):4783-5. PubMed ID: 20841509
[TBL] [Abstract][Full Text] [Related]
50. Adult Evans syndrome: complete hematologic recovery with steroids and rituximab: a case report.
Santiago-Ríos KJ; Reyes O; Cruz A; Rodríguez-Pabón N; Cáceres W
Bol Asoc Med P R; 2010; 102(2):33-6. PubMed ID: 20939201
[TBL] [Abstract][Full Text] [Related]
51. Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience.
Sanz J; Arango M; Carpio N; Montesinos P; Moscardó F; Martín G; López F; Jarque I; Lorenzo I; de la Rubia J; Solves P; Boluda B; Salazar C; Cañigral C; Sanz MA; Sanz GF
Bone Marrow Transplant; 2014 Aug; 49(8):1084-8. PubMed ID: 24887383
[TBL] [Abstract][Full Text] [Related]
52. Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort.
Westermann-Clark E; Meehan CA; Meyer AK; Dasso JF; Amre D; Ellison M; Patel B; Betensky M; Hauk CI; Mayer J; Metts J; Leiding JW; Sriaroon P; Kumar A; Ayala I; Walter JE
Front Immunol; 2021; 12():649182. PubMed ID: 33968040
[TBL] [Abstract][Full Text] [Related]
53. Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency.
Kim JJ; Thrasher AJ; Jones AM; Davies EG; Cale CM
Br J Haematol; 2007 Jul; 138(1):94-6. PubMed ID: 17498197
[TBL] [Abstract][Full Text] [Related]
54. Rituximab in immune thrombocytopenia: transient responses, low rate of sustained remissions and poor response to further therapy in refractory patients.
Aleem A; Alaskar AS; Algahtani F; Rather M; Almahayni MH; Al-Momen A
Int J Hematol; 2010 Sep; 92(2):283-8. PubMed ID: 20640541
[TBL] [Abstract][Full Text] [Related]
55. Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia.
Conti F; Gottardi F; Moratti M; Belotti T; Ferrari S; Selva P; Bassi M; Zama D; Pession A
Platelets; 2022 Jul; 33(5):801-806. PubMed ID: 35132908
[TBL] [Abstract][Full Text] [Related]
56. Low-dose rituximab in adult patients with primary immune thrombocytopenia.
Zaja F; Vianelli N; Volpetti S; Battista ML; Defina M; Palmieri S; Bocchia M; Medeot M; De Luca S; Ferrara F; Isola M; Baccarani M; Fanin R
Eur J Haematol; 2010 Oct; 85(4):329-34. PubMed ID: 20546023
[TBL] [Abstract][Full Text] [Related]
57. Neurological Involvement in Childhood Evans Syndrome.
Pincez T; Neven B; Le Pointe HD; Varlet P; Fernandes H; Gareton A; Leverger G; Leblanc T; Chambost H; Michel G; Pasquet M; Millot F; Hermine O; Mathian A; Hully M; Zephir H; Hamidou M; Durand JM; Perel Y; Landman-Parker J; Rieux-Laucat F; Aladjidi N
J Clin Immunol; 2019 Feb; 39(2):171-181. PubMed ID: 30671780
[TBL] [Abstract][Full Text] [Related]
58. Sustained remission of CIDP associated with Evans syndrome.
Knecht H; Baumberger M; Tobòn A; Steck A
Neurology; 2004 Aug; 63(4):730-2. PubMed ID: 15326255
[TBL] [Abstract][Full Text] [Related]
59. Successful use of rituximab in Evans syndrome and refractory immune thrombocytopenic purpura.
Kashif M; Qureshi A; Adil SN; Khurshid M
J Pak Med Assoc; 2010 Jan; 60(1):64-5. PubMed ID: 20055286
[TBL] [Abstract][Full Text] [Related]
60. Long-term remission rates after splenectomy in adults with Evans syndrome compared to immune thrombocytopenia: A single-center retrospective study.
Sulpizio ED; Raghunathan V; Shatzel JJ; Zilberman-Rudenko J; Worrest T; Sheppard BC; DeLoughery TG
Eur J Haematol; 2020 Jan; 104(1):55-58. PubMed ID: 31594025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
